Citadel Advisors’s Zosano Pharma Corporation ZSAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-814
| Closed | -$6K | – | 7505 |
|
|
2022
Q1 | $6K | Buy |
+814
| New | +$6K | ﹤0.01% | 6238 |
|
|
2021
Q4 | – | Sell |
-4,176
| Closed | -$105K | – | 7637 |
|
|
2021
Q3 | $105K | Buy |
4,176
+3,028
| +264% | +$76.1K | ﹤0.01% | 5847 |
|
|
2021
Q2 | $38K | Sell |
1,148
-3,444
| -75% | -$114K | ﹤0.01% | 6259 |
|
|
2021
Q1 | $199K | Buy |
+4,592
| New | +$199K | ﹤0.01% | 5421 |
|
|
2020
Q2 | – | Sell |
-1,322
| Closed | -$26K | – | 5531 |
|
|
2020
Q1 | $26K | Buy |
+1,322
| New | +$26K | ﹤0.01% | 4632 |
|
|
2018
Q4 | – | Sell |
-378
| Closed | -$54K | – | 5111 |
|
|
2018
Q3 | $54K | Buy |
+378
| New | +$54K | ﹤0.01% | 4001 |
|
|
2018
Q1 | – | Sell |
-97
| Closed | -$35K | – | 4560 |
|
|
2017
Q4 | $35K | Buy |
+97
| New | +$35K | ﹤0.01% | 3699 |
|